Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute respiratory failure in children.

S T Bateman1, J H Arnold

  • 1Department of Anesthesia/Critical Care, Children's Hospital, MICU, Boston, Massachusetts 02115, USA. bateman@a1.tch.harvard.edu

Current Opinion in Pediatrics
|June 3, 2000
PubMed
Summary

New strategies for pediatric acute respiratory failure focus on reducing lung injury and exploring immunomodulation. Promising therapies include early surfactant and enteral anti-inflammatory treatments, while inhaled nitric oxide shows limited benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poisonings requiring admission to the pediatric intensive care unit: A 5-year review.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

Urethritis in the male; an analysis of 205 cases and a review of the American literature on this subject.

Medical record and annals·2010
Same author

High-frequency ventilation in the pediatric intensive care unit.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2003
Same author

High-frequency oscillatory ventilation in pediatric patients.

Respiratory care clinics of North America·2002
Same author

Identification of optimal lung volume during high-frequency oscillatory ventilation using respiratory inductive plethysmography.

Critical care medicine·2002
Same author

Measurement of the alveolar deadspace: are we there yet?

Critical care medicine·2001

Area of Science:

  • Pediatric critical care medicine
  • Respiratory physiology
  • Immunomodulation therapies

Background:

  • Acute respiratory failure in children presents significant challenges.
  • Ventilator-induced lung injury (VILI) is a concern, observed in animal models and adults.
  • Previous research explored various treatments, including mechanical ventilation strategies and immunomodulatory agents.

Purpose of the Study:

  • To review recent advancements in treating pediatric acute respiratory failure.
  • To evaluate novel therapeutic approaches aimed at reducing ventilator-induced lung injury and improving patient outcomes.
  • To assess the efficacy of immunomodulatory therapies in pediatric respiratory failure.

Main Methods:

  • Review of recent studies on pediatric acute respiratory failure treatments.

Related Experiment Videos

  • Analysis of findings related to mechanical ventilation strategies (e.g., low tidal volume, high positive end-expiratory pressure).
  • Evaluation of adjunctive therapies such as inhaled nitric oxide, intratracheal surfactant, enteral anti-inflammatory/antioxidant agents, and corticosteroids.

    • Main Results:

    • Low tidal volume and high positive end-expiratory pressure strategies show survival benefits in adults.
    • Inhaled nitric oxide provides transient oxygenation improvements but no proven outcome benefits.
    • Early intratracheal surfactant may reduce mechanical ventilation duration; enteral anti-inflammatory/antioxidant therapies show promise in surrogate outcomes; corticosteroids may benefit late-stage lung injury.

    Conclusions:

    • Reducing ventilator-induced lung injury and exploring immunomodulation are key research areas.
    • Early surfactant administration and enteral therapies hold promise for improving outcomes in pediatric respiratory failure.
    • Further research is needed to confirm the efficacy of novel therapies, including corticosteroids, in pediatric populations.